Literature DB >> 34156523

Remote proctoring for high-risk coronary interventions with mechanical circulatory support during COVID-19 pandemic and beyond.

Felix J Woitek1, Stephan Haussig1, Johannes Mierke1, Axel Linke1, Norman Mangner2.   

Abstract

Remote proctoring by advanced digital technologies may help to overcome pandemic, geographic, and resource-related constraints for mentoring and educating interventional cardiology skills. We present a case series of patients undergoing high-risk percutaneous coronary intervention (HR-PCI) with mechanical circulatory support (MCS) guided by remote proctoring to gain insights into a streaming technology platform with regard to video/audio quality, visibility of all structural and imaging details, and delay in transmission. According to our experience, remote proctoring appears to be a reliable, quick, and resource-conserving way to disseminate, educate and improve MCS-supported HR-PCI with implications far beyond the COVID-19 pandemic.
© 2021. The Author(s).

Entities:  

Keywords:  High-risk PCI; Impella; Mechanical circulatory support; Remote proctoring

Mesh:

Year:  2021        PMID: 34156523      PMCID: PMC8217783          DOI: 10.1007/s00392-021-01890-3

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


Sirs: With the appearance of a novel coronavirus, severe acute respiratory syndrome coronavirus-2, and the consequential pandemic [1], strict private- and business-related travel restrictions became necessary and have been implemented. Interventional and surgical specialties particularly depend on practical education to provide high-quality care for patients. Mastering certain procedures is often realized by on-site proctoring by an experienced external operator; however, the travel ban has restricted those activities. On the other hand, many hospitals have reduced their elective program including cardiovascular procedures to provide structural and personal resources to handle patients with coronavirus disease 19 (Covid-19) [2]. Postponing procedures in the cardiovascular medicine has to balance the risks and benefits of this decision since some cardiovascular interventions in certain clinical situations are not truly elective. The European Association of Percutaneous Cardiovascular Interventions has provided a consensus document how patients and cardiovascular procedures should be prioritized [3]. According to these criteria, patients with acute coronary syndrome or coronary artery diseases having symptoms according to Canadian Cardiovascular Society class IV and/or require left main stem percutaneous intervention (PCI) or last-remaining vessel PCI should not be postponed and must be treated urgently. Those patients are often characterized by relevant comorbidities, reduced left ventricular ejection fraction and complex coronary artery disease fulfilling the criteria for high-risk (HR) PCI, thereby qualifying for short-term mechanical circulatory support (MCS) [4]. The Impella® 2.5 and CP heart pumps are nowadays the most often used MCS in the setting of HR-PCI [5]. However, the application can be associated with substantial complications including bleeding, access site complications and stroke negatively affecting the outcome of those patients [5]. It has been shown that the establishment of a MCS program is characterized by a certain learning curve on both the operator and center level [4, 6]. Against this background, we used a remote proctoring system: (1) to test the feasibility of this system for remote proctoring of MCS-supported HR-PCI with regard to video/audio quality, visibility of all structural and imaging details, and delay in transmission and (2) to perform educational sessions on MCS-supported HR-PCI for physicians and technical staff. The remote proctoring system was provided by TEGUS Medical (TEGUS Medical, Hamburg, Germany). It consists of the following hardware that is placed in the cath lab: (1) a 360° rotatable and 180° tiltable high definition PTZ network camera (1920 × 1080 resolution; with optical zoom and optimized framerate) which is mounted to a purpose built stand-alone freely moveable tripod, (2) a small form factor server, which enables data transformation and online access, and (3) a lightweight Bluetooth headset for audio communication with the operator (Fig. 1A). The proctor uses any conventional desktop computer to connect to the cath lab via an online platform developed for on-demand visual and acoustic live streaming (Fig. 1B). There is no recording, only livestreams are used with no sensible data storage. The online platform is programmed, provided and maintained by TEGUS Medical (Hamburg, Germany). Access to the platform is password secured and data transfer is encrypted. After logging into the platform, the proctor is able to navigate the camera inside the cath lab and zoom into any spot, e.g., the hands of the operator, the imaging screens or the Impella® controller simply via a mouse click-to-move approach, e.g., clicking on the area of interest directly on the screen. The focus and brightness are controlled automatically to facilitate ease of use for the proctor; however, additional function buttons to pause audio transmission and manually adjust the focus and brightness are also provided. A “preset” function is also provided to enable quick movement between predefined views (Fig. 2).
Fig. 1

TEGUS remote proctoring system showing the stand-alone freely moveable tripod with focus on the high definition camera and the Bluetooth headset (A). The stand-alone freely moveable tripod is best positioned at the foot of the floating cath lab table (red box in the lower part of the B) providing the audiovisual connection to the proctor in the password secured and encrypted data transfer TEGUS platform (upper part of B)

Fig. 2

Screenshots from the TEGUS online platform of the operating field (A), angiography (B), intravascular ultrasound (C), the Impella® controller (D), and hemodynamics (E)

TEGUS remote proctoring system showing the stand-alone freely moveable tripod with focus on the high definition camera and the Bluetooth headset (A). The stand-alone freely moveable tripod is best positioned at the foot of the floating cath lab table (red box in the lower part of the B) providing the audiovisual connection to the proctor in the password secured and encrypted data transfer TEGUS platform (upper part of B) Screenshots from the TEGUS online platform of the operating field (A), angiography (B), intravascular ultrasound (C), the Impella® controller (D), and hemodynamics (E) We performed six HR-PCI cases with Impella® support under remote proctoring. Patients are included the Dresden Impella Registry that has been approved by the Ethics Committee at TU Dresden (EK 457-122-014). Patient- and procedural details as well as in-hospital outcomes are outlined in the Table 1. Patients represented a typical cohort for HR-PCI with Impella 2.5 and a single access strategy used in all cases. Extensive lesion preparation including rotablation and cutting balloon PCI was performed. All procedures were successful without in-hospital complications and discharge to home the following day in the majority of patients.
Table 1

Baseline characteristics, procedural details and in-hospital outcomes

Patient # 1Patient # 2Patient # 3Patient # 4Patient # 5Patient # 6
Patient characteristics
 Age, years868986678186
 Sexmalemalemalemalemalemale
 Body mass index, (kg/m2)26.822.926.132.534.432.7
 Clinical presentationUnstable angina pectorisNSTEMICardiac decompensationCardiac decompensationNSTEMINSTEMI
 ComorbiditiesArterial hypertension, status post 2-chamber-pacemaker due to sick sinus syndrome, previous strokeArterial hypertension, PAD, carotid disease, chronic renal disease (GFR 39 ml/min)Arterial hypertension, PAD, Diabetes mellitus, COPD, chronic renal failure (GFR 61 ml/min)Arterial hypertension, carotid disease, complex PAD with recent femoral-popliteal bypass left and lower leg amputation right, hip replacement, consequently poor mobilityArterial hypertension, diabetes mellitusArterial hypertension, chronic renal failure (GFR 60 ml/min)
 Previous myocardial infarctionNoNoNoNoNoNo
 Previous PCINoYes (RCA 1 week before HR-PCI)NoNoNoNo
 Previous cardiac surgeryNoNoNoNoNoNo
 LV-EF, %402517236535
 Valvular heart diseaseNoAS II°, MR II°NoAS II°, TR II°AS I°, MS II°, MR II°No
Procedural characteristics
 Impella®2.52.52.52.52.52.5
 Access siteRight common femoral arteryLeft common femoral arteryRight common femoral arteryRight common femoral arteryRight common femoral arteryLeft common femoral artery
 Single access strategyYesYesYesYesYesYes
 Coronary artery disease2-vessel disease3-vessel disease3-vessel disease3-vessel disease3-vessel diseases3-vessel disease
Dominanceleftrightleftrightleftright
 Left main > 50%Yes (Medina 1-1-0)Yes (Medina 1-1-1)Yes (Medina 1-0-0)Yes (Medina 1-1-1)Yes (Medina 1-1-1)Yes (Medina 1-1-1)
 Proximal LAD > 75%YesYesNoYesYesYes
 CTONoNoNoYes (RCA)Yes (RCA)No
 Target vessel(s)Left main, LADLeft main, LAD, CxLeft mainLeft main, LAD, CxLeft main, LAD, CxLeft main, LAD, Cx
 RotablationNoNoNoYes (left main/Cx)Yes (left main/LAD + left main/Cx)Yes (left main/LAD)
 Cutting balloonYesNoYesNoYesNo
 Bifurcation techniqueProvisional Stenting left mainMini-Crush left mainNoDK-Crush left mainDK-Crush left mainDK-Crush left main
 Intravascular imaging useNoNoNoNoIVUSIVUS
 Access site closureMANTA 14FMANTA 14FMANTA 14FMANTA 14FMANTA 14FMANTA 14F
 Procedure duration, min9010865126157114
 Contrast dye, cc150200170100170240
 Fluoroscopy, min14.211.29.12940.325.4
In-hospital outcomes
 DeathNoNoNoNoNoNo
 Acute renal failureNoNoNoNoNoNo
 StrokeNoNoNoNoNoNo
 Major vascular complicationNoNoNoNoNoNo
 Major bleedingNoNoNoNoNoNo
 Length of hospital stay after PCI, days111713

NSTEMI non-ST segment elevation myocardial infarction, PAD peripheral artery disease, COPD chronic obstructive pulmonary disease, RCA right coronary artery, (HR)-PCI (high-risk) percutaneous coronary intervention, AS aortic stenosis, MR mitral regurgitation, TR tricuspid regurgitation, MS mitral stenosis, LAD left anterior descending coronary artery, Cx circumflex coronary artery, CTO chronic total occlusion, IVUS intravascular ultrasound

Baseline characteristics, procedural details and in-hospital outcomes NSTEMI non-ST segment elevation myocardial infarction, PAD peripheral artery disease, COPD chronic obstructive pulmonary disease, RCA right coronary artery, (HR)-PCI (high-risk) percutaneous coronary intervention, AS aortic stenosis, MR mitral regurgitation, TR tricuspid regurgitation, MS mitral stenosis, LAD left anterior descending coronary artery, Cx circumflex coronary artery, CTO chronic total occlusion, IVUS intravascular ultrasound The TEGUS remote proctoring system provided a stable and high-quality video and audio signal throughout all procedures from initial puncture till access site closure. With maximum zoom, the resolution was high enough to clearly identify the interventional equipment and angiography on the screen, in particular IVUS pictures were clearly visible. Not only the procedure, but also the preparation of the Impella® heart pump and the controller could be supervised and in case of any alarms, advise for troubleshooting was given. In our setting, audio connection was only established between the proctor and the operator via a Bluetooth headset and not to the whole cath lab team. Audio connection is also possible via a remote loudspeaker which might have the advantage to provide direct advice to the unsterile cath lab staff, e.g., for adjustments at the Impella® controller. In one case, the hospital internet was disturbed; however, the integrated 4G mobile router maintained a stable connection between the proctor and operator. With both connections, no relevant lag in transmission was observed which is an important finding since in HR-PCI cases certain decisions have to be made immediately. Moreover, physicians and staff members attending as invited viewers on the secured website also reported on high-quality audio and video signals without lag in transmission indicating that the TEGUS system is not only a viable option for remote proctoring but also for streaming of educational sessions performed by an operator and potentially commented by the proctor. Remote proctoring has been developed in operative disciplines [7], and has recently been described in a structural intervention case performing reverse LAMPOON (intentional laceration of the anterior mitral valve leaflet to prevent left ventricular outflow obstruction)-assisted transcatheter mitral valve implantation [8]. The TEGUS system was specifically developed for endovascular interventions and has been primarily introduced in a neurovascular scenario [9, 10]. To our knowledge, this is the first report on a series of remote proctored MCS-supported HR-PCI cases with the TEGUS system suggesting the applicability of this approach. Interventional cardiology and cardiac catheterization expertise is critical to the success of a percutaneous MCS program. As mentioned before, a significant learning curve exists and investment in training of the operator and the whole team is necessary to improve patient care and hemodynamic support by the MCS [4]. Our report has certain limitations: (1) Interventions and proctoring were performed by two experienced interventional cardiologists working together for several years. Therefore, proctoring between two unknown persons might be different. (2) Cases have been discussed face-to-face between the operator and proctor before. In real remote proctoring cases, patient’s characteristics, diagnostic findings, and the procedural strategy should be discussed in advance via a virtual meeting. (3) Stable internet connections are a prerequisite for this kind of proctoring with technical network requirements provided by TEGUS Medical. Remote proctoring appears to be a reliable, quick, and resource-conserving way to disseminate, educate and improve MCS-supported HR-PCI in particular and interventional cardiology skills in general. The application of this approach is far beyond the COVID-19 pandemic.
  10 in total

1.  Evaluating the learning curve in the prospective Randomized Clinical Trial of hemodynamic support with Impella 2.5 versus Intra-Aortic Balloon Pump in patients undergoing high-risk percutaneous coronary intervention: a prespecified subanalysis of the PROTECT II study.

Authors:  José P S Henriques; Dagmar M Ouweneel; Srihari S Naidu; Igor F Palacios; Jeffrey Popma; E Magnus Ohman; William W O'Neill
Journal:  Am Heart J       Date:  2014-01-03       Impact factor: 4.749

2.  Telemedicine and telementoring in the surgical specialties: A narrative review.

Authors:  Eunice Y Huang; Samantha Knight; Camila Roginski Guetter; Catherine Hambleton Davis; Mecker Moller; Eliza Slama; Marie Crandall
Journal:  Am J Surg       Date:  2019-07-18       Impact factor: 2.565

3.  Training and Supervision of Thrombectomy by Remote Live Streaming Support (RESS) : Randomized Comparison Using Simulated Stroke Interventions.

Authors:  Matthias Bechstein; Jan-Hendrik Buhk; Andreas Maximilian Frölich; Gabriel Broocks; Uta Hanning; Martin Erler; Milan Anđelković; Dragan Debeljak; Jens Fiehler; Einar Goebell
Journal:  Clin Neuroradiol       Date:  2019-12-20       Impact factor: 3.649

Review 4.  A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective.

Authors:  Tamara M Atkinson; E Magnus Ohman; William W O'Neill; Tanveer Rab; Joaquin E Cigarroa
Journal:  JACC Cardiovasc Interv       Date:  2016-05-09       Impact factor: 11.195

5.  The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support.

Authors:  Amit P Amin; John A Spertus; Jeptha P Curtis; Nihar Desai; Frederick A Masoudi; Richard G Bach; Christian McNeely; Firas Al-Badarin; John A House; Hemant Kulkarni; Sunil V Rao
Journal:  Circulation       Date:  2019-11-17       Impact factor: 29.690

6.  Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors:  Alaide Chieffo; Giuseppe Tarantini; Christoph Kurt Naber; Emanuele Barbato; Marco Roffi; Giulio G Stefanini; Gill Louise Buchanan; Piotr Buszman; Raúl Moreno; Barbara Zawiślak; Guillaume Cayla; Haim Danenberg; Joao Antonio Brum Da Silveira; Holger Nef; Stefan K James; Josepa Mauri Ferre; Michiel Voskuil; Nils Witt; Stephan Windecker; Andreas Baumbach; Dariusz Dudek
Journal:  EuroIntervention       Date:  2021-02-19       Impact factor: 6.534

7.  Hospitalization deficit of in- and outpatient cases with cardiovascular diseases and utilization of cardiological interventions during the COVID-19 pandemic: Insights from the German-wide helios hospital network.

Authors:  Sebastian König; Laura Ueberham; Vincent Pellissier; Sven Hohenstein; Andreas Meier-Hellmann; Holger Thiele; Vusal Ahmadli; Michael A Borger; Ralf Kuhlen; Gerhard Hindricks; Andreas Bollmann
Journal:  Clin Cardiol       Date:  2021-01-26       Impact factor: 3.287

8.  The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.

Authors:  David S Hui; Esam I Azhar; Tariq A Madani; Francine Ntoumi; Richard Kock; Osman Dar; Giuseppe Ippolito; Timothy D Mchugh; Ziad A Memish; Christian Drosten; Alimuddin Zumla; Eskild Petersen
Journal:  Int J Infect Dis       Date:  2020-01-14       Impact factor: 3.623

Review 9.  Role of Teleproctoring in Challenging and Innovative Structural Interventions Amid the COVID-19 Pandemic and Beyond.

Authors:  Sachin S Goel; Adam B Greenbaum; Apurva Patel; Stephen H Little; Roosha Parikh; Moritz C Wyler von Ballmoos; Alan B Lumsden; Michael J Reardon; Neal S Kleiman
Journal:  JACC Cardiovasc Interv       Date:  2020-04-16       Impact factor: 11.195

10.  Republished: Interhospital teleproctoring of endovascular intracranial aneurysm treatment using a dedicated live-streaming technology: first experiences during the COVID-19 pandemic.

Authors:  Matthias Bechstein; Samer Elsheikh; Fritz Wodarg; Christian A Taschner; Uta Hanning; Jan-Hendrik Buhk; Rosalie McDonough; Einar Goebell; Jens Fiehler; Maxim Bester
Journal:  J Neurointerv Surg       Date:  2020-10-20       Impact factor: 5.836

  10 in total
  1 in total

Review 1.  Teleproctoring for Training in Structural Heart Interventions: Initial Real-World Experience During the COVID-19 Pandemic.

Authors:  Niklas Beyhoff; Miry Zhu; Lukas Zanders; David M Leistner; Anthony Nobles; Mark Schroeder; Fabian Barbieri; Ulf Landmesser; Markus Reinthaler
Journal:  J Am Heart Assoc       Date:  2022-02-08       Impact factor: 6.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.